The Key to Biologics Success: Why Developability Assessments Matter in Antibody Discovery
In this podcast, we spoke with Dr. George Wang, Vice President of Discovery and Preclinical Services at WuXi Biologics about the importance of identifying potential manufacturing, stability, and scalability challenges early to mitigate risks, reduce ... Continued
